Millions of Paxlovid packets haven’t been used, which could be tied to COVID-19 rebound risks, less federal funds and diminishing public concern about the pandemic, according to an article published Jan. 3 in Nature.
Read the full post on Becker's Hospital Review - Healthcare News
